EDX Medical launches most world’s advanced testicular cancer test

EDX Medical launches most world’s advanced testicular cancer test

Simple blood sample used to analyse biomarkers.

Professor Sir Chris Evans on EDX Medical’s new testicular cancer test (AQSE:EDX)

EDX Medical Group Plc (AQSE:EDX) Founder and Chief Scientific Officer Professor Sir Chris Evans caught up with DirectorsTalk for an exclusive interview to discuss their new highly accurate testicular cancer test, how patients will access it, when it will be launched, how prevalent testicular cancer is, and what else investors can expect over the coming months. Q1: Chris, EDX Medical has announced the launch of a highly accurate testicular cancer…